Publication:

HUMAN CLONING AND FDA REGULATION

Thumbnail Image

Open/View Files

tvosk.pdf (225.69 KB)
 tvosk.html (68.08 KB)
 tvosk.rtf (87.01 KB)

Date

1998

Authors

Published Version

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

HUMAN CLONING AND FDA REGULATION (1998 Third Year Paper)

Abstract

In the February 27, 1997 issue of the journal Nature scientists from Scotland's Roslin Institute reported their successful efforts to clone an adult sheep using differentiated somatic cells from the animal. The clone, named Dolly, was the first instance of the successful cloning of an adult mammal. The shock waves created by the possible ramifications of this development were immediately felt around the world. For the first time, the cloning of an adult human being was no longer being considered an impossibility in mainstream scientific circles. Scientists, governments and laymen around the world were now forced to began considering the consequences of utilizing this new technology to clone adult human beings.

Description

Other Available Sources

Research Data

Keywords

Food and Drug Law, cloning, FDA regulation

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

URI

http://nrs.harvard.edu/urn-3:HUL.InstRepos:8889437

Collections

HLS Student Papers

Endorsement

Review

Supplemented By

Related Stories